Table 3.
(a,b) presents Inhibition zones of (a) ZnO nanoparticles against Pseudomonas aeruginosa, Staphylococcus aureus, E. coli, Klebsiellapneumoniae, MRSA and Salmonella typhi. (b) silver doped ZnO(Ag-ZnO) nanoparticles against Pseudomonas aeruginosa, Staphylococcus aureus, E. coli, Klebsiellapneumoniae, MRSA and Salmonella typhi.
| a | |||
|---|---|---|---|
| Bacteria | ZnO NPs | Positive control | Negative control |
| Pseudomonas aeruginosa | 0 | 29 ± 0.556 | — |
| Klebsiella pneumoniae | 9 ± 0.529 | 28 ± 0.529 | — |
| Staphylococcus aureus | 10 ± 0.624 | 10 ± 0.624 | |
| Salmonella typhi | 10 ± 0.624 | 23 ± 0.556 | — |
| MRSA | 8 ± 0.458 | 25 ± 0.53 | — |
| E. coli | 10 ± 0.493 | 29 ± 0.781 | — |
| b | |||
| Bacteria | ZnO NPs | Positive control | Negative control |
| Pseudomonas aeruginosa | 13 ± 0.458 | 27 ± 0.655 | — |
| Klebsiellapneumoniae | 14 ± 0.36 | 28 ± 0.458 | — |
| Staphylococcus aureus | 16 ± 0.818 | 25 ± 0.529 | — |
| Salmonella typhi | 19 ± 0.556 | 27 ± 0.655 | — |
| MRSA | 16 ± 0.404 | 26 ± 0.721 | — |
| E. coli | 14 ± 0.568 | 26 ± 0.656 | — |